# China Approves Eli Lilly’s Orforglipron Weight-Loss Pill By Riza Dagoc Canonical URL: https://www.tokenpost.com/news/regulation/55529 Published: 2026-11-12T14:50:36.000Z Updated: 2026-11-12T14:50:36.000Z Section: Regulation > Lilly is the first drugmaker to receive Chinese clearance for a GLP-1 weight-loss pill, giving it an early lead over Novo Nordisk. China’s medicine regulator approved Eli Lilly’s oral GLP-1 weight-loss drug orforglipron, making Lilly the first drugmaker cleared for a GLP-1 weight-loss pill in the country and giving it an early lead over Novo Nordisk. Orforglipron is the active ingredient in Foundayo. An EU expert panel has also recommended [marketing authorization for Foundayo](), moving the pill closer to possible approval in Europe. ## Links in this article - [marketing authorization for Foundayo](https://www.tokenpost.com/news/business/33429)